Cargando…

Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint Inhibitors

Immune checkpoint inhibitors (ICPi) have shown their superiority over conventional therapies to treat some cancers. ICPi are effective against immunogenic tumors. However, patients with tumors poorly infiltrated with immune cells do not respond to ICPi. Combining ICPi with other anticancer therapies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dosset, Magalie, Joseph, Elodie Lauret-Marie, Rivera Vargas, Thaiz, Apetoh, Lionel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408477/ https://www.ncbi.nlm.nih.gov/pubmed/32707692 http://dx.doi.org/10.3390/cells9071727

Ejemplares similares

Can Immunogenic Chemotherapies Relieve Cancer Cell Resistance to Immune Checkpoint Inhibitors?
por: Rivera Vargas, Thaiz, et al.
Publicado: (2019)

PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer
por: Dosset, Magalie, et al.
Publicado: (2018)

Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of T(H)9 cells
por: Rivera Vargas, Thaiz, et al.
Publicado: (2017)

T(H)9 cells in anti-tumor immunity
por: Rivera Vargas, Thaiz, et al.
Publicado: (2016)

Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy
por: Lauret Marie Joseph, Elodie, et al.
Publicado: (2021)

Telomerase and CD4 T Cell Immunity in Cancer
por: Dosset, Magalie, et al.
Publicado: (2020)

The Unfolded Protein Response at the Tumor-Immune Interface
por: Zanetti, Maurizio, et al.
Publicado: (2022)

Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?
por: Godet, Yann, et al.
Publicado: (2012)

Update on Autophagy Inhibitors in Cancer: Opening up to a Therapeutic Combination with Immune Checkpoint Inhibitors
por: Bestion, Eloïne, et al.
Publicado: (2023)

Cell-Intrinsic Roles for Autophagy in Modulating CD4 T Cell Functions
por: Jacquin, Elise, et al.
Publicado: (2018)

Biomarkers of therapeutic response with immune checkpoint inhibitors
por: Bindal, Poorva, et al.
Publicado: (2021)

Gut microbiome in modulating immune checkpoint inhibitors
por: Li, Xiang, et al.
Publicado: (2022)

Immune effects of 5-fluorouracil: Ambivalence matters
por: Ghiringhelli, François, et al.
Publicado: (2013)

Gut microbiome modulates efficacy of immune checkpoint inhibitors
por: Yi, Ming, et al.
Publicado: (2018)

Safety and Efficacy of Therapeutic Cancer Vaccines Alone or in Combination With Immune Checkpoint Inhibitors in Cancer Treatment
por: Zhao, Jing, et al.
Publicado: (2019)

Combined Use of Immune Checkpoint Inhibitors and Phytochemicals as a Novel Therapeutic Strategy against Cancer
por: Luo, LingJie, et al.
Publicado: (2023)

Abscopal effect of radiotherapy combined with immune checkpoint inhibitors
por: Liu, Yang, et al.
Publicado: (2018)

Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy
por: Yan, Yiyi, et al.
Publicado: (2018)

Combination of Immune Checkpoint Inhibitors with Chemotherapy in Lung Cancer
por: Liu, Wei, et al.
Publicado: (2020)

Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents
por: Ciciola, Paola, et al.
Publicado: (2020)

Analysis of combination therapy of immune checkpoint inhibitors in osteosarcoma
por: Peng, Lijun, et al.
Publicado: (2022)

Combination immunomodulation for immune-checkpoint-inhibitor-associated myocarditis
por: Johnson, Douglas B., et al.
Publicado: (2023)

Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
por: Akinleye, Akintunde, et al.
Publicado: (2019)

miRNA-Based Therapeutics in the Era of Immune-Checkpoint Inhibitors
por: Huemer, Florian, et al.
Publicado: (2021)

Myocarditis Induced by Immune Checkpoint Inhibitors: Mechanisms and Therapeutic Prospects
por: Zou, Wenlu, et al.
Publicado: (2021)

Identification of a novel PD-L1 positive solid tumor transplantable in HLA-A*0201/DRB1*0101 transgenic mice
por: Rangan, Laurie, et al.
Publicado: (2017)

Immune checkpoint inhibitors
por: Hui, Enfu
Publicado: (2019)

Immune checkpoint inhibitors
por: Kroemer, Guido, et al.
Publicado: (2021)

Interrogating the immune-modulating roles of radiation therapy for a rational combination with immune-checkpoint inhibitors in treating pancreatic cancer
por: Fujiwara, Kenji, et al.
Publicado: (2020)

Combined Treatment with Ultrasound and Immune Checkpoint Inhibitors for Prostate Cancer
por: Hayashi, Fuuka, et al.
Publicado: (2022)

Determinants of Resistance to Checkpoint Inhibitors
por: Tran, Linda, et al.
Publicado: (2020)

Blockade of novel immune checkpoints and new therapeutic combinations to boost antitumor immunity
por: Archilla-Ortega, Adrià, et al.
Publicado: (2022)

Therapeutic potential of DNA methyltransferase inhibitors with immune checkpoint inhibitor therapy in breast cancer
por: Luo, Na, et al.
Publicado: (2018)

Anticancer effects of the microbiota: how the microbiome shapes the development of IL-9-producing T cells
por: Apetoh, Lionel
Publicado: (2020)

Sex Disparities of Genomic Determinants in Response to Immune Checkpoint Inhibitors in Melanoma
por: Shi, Fuyan, et al.
Publicado: (2021)

Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors
por: Zapata, Luis, et al.
Publicado: (2023)

Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma
por: Huang, Jin-Tao, et al.
Publicado: (2022)

Targeting the Tumor Microenvironment for Improving Therapeutic Effectiveness in Cancer Immunotherapy: Focusing on Immune Checkpoint Inhibitors and Combination Therapies
por: Chyuan, I-Tsu, et al.
Publicado: (2021)

Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition
por: Newton, Jared M., et al.
Publicado: (2019)

Redox Signaling Modulates Activity of Immune Checkpoint Inhibitors in Cancer Patients
por: Allegra, Alessandro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oeiju0q0idgo2rnl7p2hoaispi